Mammographic screening: keeping women alive

Area of Science:

• Oncology
• Radiology
• Public Health

Background:

• The Swedish Two-County Trial evaluated the long-term impact of mammographic screening on breast cancer mortality.
• Women aged 40-69 were invited for periodic mammographic screening starting in the 1980s.

Discussion:

• The study highlights a sustained 30% reduction in breast cancer mortality over 30 years.
• A significant absolute mortality risk reduction was observed, with one death prevented for every 414 women screened over 7 years.
• Potential harms of screening, such as false positives and overdiagnosis, were found to be balanced by the mortality benefit.

Key Insights:

• Mammographic screening is a highly effective intervention for reducing breast cancer mortality.
• The benefits of screening are substantial and persist over decades.
• Screening programs can prevent multiple breast cancer deaths annually when applied nationally.

Outlook:

• Further research could refine screening protocols to optimize benefits and minimize harms.
• Continued long-term follow-up of screening cohorts is crucial for understanding evolving impacts.
• Translating trial findings into national screening policies requires careful consideration of resource allocation and population benefits.